Insider Trading activities at Myovant Sciences Ltd. (MYOV)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Myovant Sciences Ltd. (MYOV) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Myovant Sciences Ltd.. Table 2 shows the detailed insider transactions. This company's CIK number is 1679082.

Total stock buying since 2016: $2,021,794,299.
Total stock sales since 2016: $150,157,156.
Total stock option exercises since 2016: $2,232,078.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Myovant Sciences Ltd.* (*MYOV*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2023	51,599,200	$1,393,178,400	12,426	$334,134	0	$0
2022	0	$0	159,967	$2,470,649	0	$0
2021	1,400,000	$32,446,324	165,962	$3,946,354	125,258	$962,762
2020	3,632,577	$33,497,055	192,292	$4,213,445	177,600	$1,269,316
2019	26,074,183	$244,082,590	45,050,168	$649,506	0	$0
2018	16,300,745	$318,543,100	7,420,625	$138,543,068	0	$0
2017	3,500	$46,830	0	$0	30,095	$0
2016	0	$0	0	$0	1,999,410	$0

Table 2. Monthly summary of insider trading at *Myovant Sciences Ltd.* (*MYOV*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2023-03	51,599,200	$1,393,178,400	0	$0	0	$0
2023-01	0	$0	12,426	$334,134	0	$0
2022-12	0	$0	2,241	$59,946	0	$0
2022-10	0	$0	16,396	$413,177	0	$0
2022-09	0	$0	9,243	$174,322	0	$0
2022-08	0	$0	31,214	$569,031	0	$0
2022-07	0	$0	22,866	$297,705	0	$0
2022-05	0	$0	1,382	$13,916	0	$0
2022-04	0	$0	48,635	$522,746	0	$0
2022-03	0	$0	1,362	$18,182	0	$0
2022-01	0	$0	26,628	$401,624	0	$0
2021-11	0	$0	5,778	$129,437	3,800	$29,564
2021-10	0	$0	9,409	$203,422	0	$0
2021-09	913,405	$21,536,513	60,358	$1,508,116	60,358	$462,647
2021-08	486,595	$10,909,811	22,978	$549,930	21,000	$163,380
2021-07	0	$0	12,963	$280,345	0	$0
2021-05	0	$0	3,083	$73,992	1,300	$10,114
2021-04	0	$0	11,080	$206,420	0	$0
2021-03	0	$0	38,513	$955,318	37,000	$287,860
2021-02	0	$0	750	$16,049	750	$3,832
2021-01	0	$0	1,050	$23,325	1,050	$5,365
2020-12	0	$0	61,850	$1,620,963	61,850	$446,883
2020-11	0	$0	18,978	$392,779	17,000	$124,249
2020-09	0	$0	7,750	$171,032	7,750	$58,292

Table 3. Detailed insider trading at *Myovant Sciences Ltd.* (*MYOV*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2023-03-10	Sumitovant Biopharma Ltd. (10% Owner)	Buy	51,599,200	27.00	1,393,178,400
2023-01-18	Merendino Lauren (Chief Commercial Officer)	Sale	2,008	26.89	53,995
2023-01-18	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	1,109	26.89	29,821
2023-01-18	Lang Matthew (General Counsel & Corp. Secy.)	Sale	1,272	26.89	34,204
2023-01-18	Marek David C (Principal Executive Officer)	Sale	8,037	26.89	216,114
2022-12-16	Mehra Uneek (Principal Financial Officer)	Sale	2,241	26.75	59,946
2022-10-18	Merendino Lauren (Chief Commercial Officer)	Sale	1,703	25.20	42,915
2022-10-18	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	1,604	25.20	40,420
2022-10-18	Lang Matthew (General Counsel & Corp. Secy.)	Sale	1,933	25.20	48,711
2022-10-18	Marek David C (Principal Executive Officer)	Sale	11,156	25.20	281,131
2022-09-16	Mehra Uneek (Principal Financial Officer)	Sale	9,243	18.86	174,322
2022-08-15	Lang Matthew (General Counsel & Corp. Secy.)	Sale	31,214	18.23	569,031
2022-07-18	Merendino Lauren (Chief Commercial Officer)	Sale	1,704	12.87	21,930
2022-07-18	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	1,606	12.87	20,669
2022-07-18	Lang Matthew (General Counsel & Corp. Secy.)	Sale	1,935	12.87	24,903
2022-07-18	Marek David C (Principal Executive Officer)	Sale	11,164	12.87	143,680
2022-07-06	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	2,755	13.40	36,917
2022-07-06	Lang Matthew (General Counsel & Corp. Secy.)	Sale	3,702	13.40	49,606
2022-05-27	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	1,382	10.07	13,916
2022-04-19	Merendino Lauren (Chief Commercial Officer)	Sale	7,049	10.45	73,662
2022-04-19	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	4,632	10.45	48,404
2022-04-19	Lang Matthew (General Counsel & Corp. Secy.)	Sale	8,002	10.45	83,620
2022-04-19	Marek David C (Principal Executive Officer)	Sale	24,594	10.45	257,007
2022-04-05	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	1,922	13.78	26,485
2022-04-05	Lang Matthew (General Counsel & Corp. Secy.)	Sale	2,436	13.78	33,568
2022-03-01	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	1,362	13.35	18,182
2022-01-19	Marek David C (Principal Executive Officer)	Sale	19,882	14.68	291,867
2022-01-04	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	2,271	16.27	36,949
2022-01-04	Lang Matthew (General Counsel & Corp. Secy.)	Sale	4,475	16.27	72,808
2021-11-29	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	1,978	19.30	38,175
2021-11-04	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	3,100	24.02	74,462
2021-11-04	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	3,100	7.78	24,118
2021-11-03	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	700	24.00	16,800
2021-11-03	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	700	7.78	5,446
2021-10-05	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	2,738	21.62	59,195
2021-10-05	Lang Matthew (General Counsel & Corp. Secy.)	Sale	6,671	21.62	144,227
2021-09-28	Sumitovant Biopharma Ltd. (10% Owner)	Buy	20,677	22.85	472,386
2021-09-27	Sumitovant Biopharma Ltd. (10% Owner)	Buy	48,000	24.52	1,177,056
2021-09-27	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	7,000	24.32	170,240
2021-09-27	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	7,000	7.78	54,460
2021-09-24	Sumitovant Biopharma Ltd. (10% Owner)	Buy	36,000	23.40	842,544
2021-09-23	Sumitovant Biopharma Ltd. (10% Owner)	Buy	54,778	23.25	1,273,698
2021-09-22	Sumitovant Biopharma Ltd. (10% Owner)	Buy	84,018	21.96	1,845,035
2021-09-21	Sumitovant Biopharma Ltd. (10% Owner)	Buy	43,000	22.48	966,468
2021-09-20	Sumitovant Biopharma Ltd. (10% Owner)	Buy	38,273	22.10	845,680
2021-09-17	Sumitovant Biopharma Ltd. (10% Owner)	Buy	37,913	22.79	864,113
2021-09-16	Sumitovant Biopharma Ltd. (10% Owner)	Buy	50,000	21.75	1,087,550
2021-09-15	Sumitovant Biopharma Ltd. (10% Owner)	Buy	89,864	21.98	1,975,480
2021-09-14	Sumitovant Biopharma Ltd. (10% Owner)	Buy	71,300	22.40	1,596,834
2021-09-13	Sumitovant Biopharma Ltd. (10% Owner)	Buy	83,178	23.50	1,954,599
2021-09-10	Sumitovant Biopharma Ltd. (10% Owner)	Buy	30,000	25.11	753,390
2021-09-09	Sumitovant Biopharma Ltd. (10% Owner)	Buy	37,000	25.52	944,166
2021-09-09	Curran Terrie (Director)	Sale	4,850	25.58	124,062
2021-09-09	Curran Terrie (Director)	Option Ex	4,850	7.65	37,102
2021-09-08	Sumitovant Biopharma Ltd. (10% Owner)	Buy	21,902	25.74	563,669
2021-09-07	Sumitovant Biopharma Ltd. (10% Owner)	Buy	33,200	26.60	883,120
2021-09-03	Sumitovant Biopharma Ltd. (10% Owner)	Buy	31,200	27.02	842,899
2021-09-02	Sumitovant Biopharma Ltd. (10% Owner)	Buy	63,102	26.22	1,654,786
2021-09-02	Curran Terrie (Director)	Sale	37,135	25.03	929,489
2021-09-02	Curran Terrie (Director)	Option Ex	37,135	7.65	284,082
2021-09-01	Sumitovant Biopharma Ltd. (10% Owner)	Buy	40,000	24.83	993,040
2021-09-01	Curran Terrie (Director)	Sale	11,373	25.00	284,325
2021-09-01	Curran Terrie (Director)	Option Ex	11,373	7.65	87,003
2021-08-31	Sumitovant Biopharma Ltd. (10% Owner)	Buy	39,000	24.28	946,881
2021-08-30	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	23.92	1,674,120
2021-08-30	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	21,000	24.05	505,050
2021-08-30	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	21,000	7.78	163,380
2021-08-27	Sumitovant Biopharma Ltd. (10% Owner)	Buy	37,038	23.17	858,244
2021-08-27	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	1,978	22.69	44,880
2021-08-26	Sumitovant Biopharma Ltd. (10% Owner)	Buy	40,000	22.67	906,919
2021-08-25	Sumitovant Biopharma Ltd. (10% Owner)	Buy	28,709	22.44	644,172
2021-08-24	Sumitovant Biopharma Ltd. (10% Owner)	Buy	34,299	22.37	767,268
2021-08-23	Sumitovant Biopharma Ltd. (10% Owner)	Buy	55,447	22.29	1,235,858
2021-08-20	Sumitovant Biopharma Ltd. (10% Owner)	Buy	46,478	20.86	969,531
2021-08-19	Sumitovant Biopharma Ltd. (10% Owner)	Buy	46,792	21.51	1,006,402
2021-08-18	Sumitovant Biopharma Ltd. (10% Owner)	Buy	17,116	21.45	367,086
2021-08-17	Sumitovant Biopharma Ltd. (10% Owner)	Buy	23,549	20.89	492,056
2021-08-16	Sumitovant Biopharma Ltd. (10% Owner)	Buy	48,167	21.62	1,041,274
2021-07-09	Lang Matthew (General Counsel & Corp. Secy.)	Sale	6,954	21.52	149,650
2021-07-07	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	2,777	21.75	60,399
2021-07-07	Karbe Frank (Principal Fin'l & Accounting)	Sale	3,232	21.75	70,296
2021-05-28	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	3,083	24.00	73,992
2021-05-28	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	1,300	7.78	10,114
2021-04-06	Karbe Frank (Principal Fin'l & Accounting)	Sale	11,080	18.63	206,420
2021-03-19	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	7,000	24.17	169,190
2021-03-19	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	7,000	7.78	54,460
2021-03-15	Lang Matthew (General Counsel & Corp. Secy.)	Sale	30,000	25.07	752,010
2021-03-15	Lang Matthew (General Counsel & Corp. Secy.)	Option Ex	30,000	7.78	233,400
2021-03-01	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	1,513	22.55	34,118
2021-02-16	Karbe Frank (Principal Fin'l & Accounting)	Sale	750	21.40	16,049
2021-02-16	Karbe Frank (Principal Fin'l & Accounting)	Option Ex	750	5.11	3,832
2021-01-28	Karbe Frank (Principal Fin'l & Accounting)	Sale	300	24.00	7,200
2021-01-28	Karbe Frank (Principal Fin'l & Accounting)	Option Ex	300	5.11	1,533
2021-01-15	Karbe Frank (Principal Fin'l & Accounting)	Sale	750	21.50	16,125
2021-01-15	Karbe Frank (Principal Fin'l & Accounting)	Option Ex	750	5.11	3,832
2020-12-28	Karbe Frank (Principal Fin'l & Accounting)	Sale	11,800	30.00	354,000
2020-12-28	Karbe Frank (Principal Fin'l & Accounting)	Option Ex	11,800	5.11	60,298
2020-12-18	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	2,000	26.00	52,000
2020-12-18	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	2,000	7.78	15,560
2020-12-18	Lang Matthew (General Counsel & Corp. Secy.)	Sale	10,000	25.81	258,080
2020-12-18	Lang Matthew (General Counsel & Corp. Secy.)	Option Ex	10,000	7.78	77,800
2020-12-15	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	7,000	23.92	167,447
2020-12-15	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	7,000	7.78	54,460
2020-12-15	Karbe Frank (Principal Fin'l & Accounting)	Sale	1,050	24.04	25,244
2020-12-15	Karbe Frank (Principal Fin'l & Accounting)	Option Ex	1,050	5.11	5,365
2020-12-10	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	10,000	26.04	260,360
2020-12-10	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	10,000	7.78	77,800
2020-12-10	Lang Matthew (General Counsel & Corp. Secy.)	Sale	19,400	25.20	488,783
2020-12-10	Lang Matthew (General Counsel & Corp. Secy.)	Option Ex	19,400	7.78	150,932
2020-12-09	Lang Matthew (General Counsel & Corp. Secy.)	Sale	600	25.08	15,049
2020-12-09	Lang Matthew (General Counsel & Corp. Secy.)	Option Ex	600	7.78	4,668
2020-11-30	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	1,978	23.65	46,779
2020-11-30	Karbe Frank (Principal Fin'l & Accounting)	Sale	1,500	24.00	36,000
2020-11-30	Karbe Frank (Principal Fin'l & Accounting)	Option Ex	1,500	5.11	7,665
2020-11-17	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	7,000	20.00	140,000
2020-11-17	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	7,000	7.78	54,460
2020-11-17	Karbe Frank (Principal Fin'l & Accounting)	Sale	750	20.00	15,000
2020-11-17	Karbe Frank (Principal Fin'l & Accounting)	Option Ex	750	5.11	3,832
2020-11-13	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	7,000	20.00	140,000
2020-11-13	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	7,000	7.78	54,460
2020-11-13	Karbe Frank (Principal Fin'l & Accounting)	Sale	750	20.00	15,000
2020-11-13	Karbe Frank (Principal Fin'l & Accounting)	Option Ex	750	5.11	3,832
2020-09-15	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	7,000	22.11	154,735
2020-09-15	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	7,000	7.78	54,460
2020-09-15	Karbe Frank (Principal Fin'l & Accounting)	Sale	750	21.73	16,297
2020-09-15	Karbe Frank (Principal Fin'l & Accounting)	Option Ex	750	5.11	3,832
2020-08-31	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	11,307	20.00	226,196
2020-08-31	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	11,307	7.78	87,968
2020-08-31	Lang Matthew (General Counsel & Corp. Secy.)	Sale	26,700	20.05	535,281
2020-08-31	Lang Matthew (General Counsel & Corp. Secy.)	Option Ex	26,700	7.78	207,726
2020-08-31	Karbe Frank (Principal Fin'l & Accounting)	Sale	21,150	20.01	423,274
2020-08-31	Karbe Frank (Principal Fin'l & Accounting)	Option Ex	21,150	5.11	108,076
2020-08-28	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	2,058	20.01	41,180
2020-08-28	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	2,058	7.78	16,011
2020-08-28	Lang Matthew (General Counsel & Corp. Secy.)	Sale	2,600	20.02	52,052
2020-08-28	Lang Matthew (General Counsel & Corp. Secy.)	Option Ex	2,600	7.78	20,228
2020-08-28	Karbe Frank (Principal Fin'l & Accounting)	Sale	3,650	20.04	73,146
2020-08-28	Karbe Frank (Principal Fin'l & Accounting)	Option Ex	3,650	5.11	18,651
2020-08-27	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	7,089	18.80	133,273
2020-08-26	Lang Matthew (General Counsel & Corp. Secy.)	Sale	100	20.00	2,000
2020-08-26	Lang Matthew (General Counsel & Corp. Secy.)	Option Ex	100	7.78	778
2020-08-19	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	635	20.00	12,700
2020-08-19	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	635	7.78	4,940
2020-08-19	Lang Matthew (General Counsel & Corp. Secy.)	Sale	600	20.00	12,000
2020-08-19	Lang Matthew (General Counsel & Corp. Secy.)	Option Ex	600	7.78	4,668
2020-08-19	Karbe Frank (Principal Fin'l & Accounting)	Sale	700	20.00	14,000
2020-08-19	Karbe Frank (Principal Fin'l & Accounting)	Option Ex	700	5.11	3,577
2020-06-24	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	17,446	20.00	348,920
2020-06-24	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	17,446	7.78	135,729
2020-06-23	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	4,054	20.00	81,080
2020-06-23	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Option Ex	4,054	7.78	31,540
2020-05-20	Sumitovant Biopharma Ltd. (10% Owner)	Buy	37,897	12.58	476,857
2020-05-19	Sumitovant Biopharma Ltd. (10% Owner)	Buy	50,000	12.10	605,050
2020-05-18	Sumitovant Biopharma Ltd. (10% Owner)	Buy	35,000	12.36	432,635
2020-05-15	Sumitovant Biopharma Ltd. (10% Owner)	Buy	49,812	12.12	603,970
2020-05-14	Sumitovant Biopharma Ltd. (10% Owner)	Buy	50,000	12.02	600,750
2020-05-13	Sumitovant Biopharma Ltd. (10% Owner)	Buy	41,331	12.38	511,636
2020-05-12	Sumitovant Biopharma Ltd. (10% Owner)	Buy	24,448	13.52	330,414
2020-05-11	Sumitovant Biopharma Ltd. (10% Owner)	Buy	35,000	12.78	447,370
2020-05-08	Sumitovant Biopharma Ltd. (10% Owner)	Buy	35,000	12.83	449,085
2020-05-07	Sumitovant Biopharma Ltd. (10% Owner)	Buy	35,000	12.63	442,154
2020-05-05	Sumitovant Biopharma Ltd. (10% Owner)	Buy	100,000	11.96	1,196,500
2020-05-04	Sumitovant Biopharma Ltd. (10% Owner)	Buy	50,000	11.50	574,850
2020-05-01	Sumitovant Biopharma Ltd. (10% Owner)	Buy	50,000	11.38	569,200
2020-04-30	Sumitovant Biopharma Ltd. (10% Owner)	Buy	50,000	12.08	603,850
2020-04-29	Sumitovant Biopharma Ltd. (10% Owner)	Buy	50,000	11.92	595,900
2020-04-28	Sumitovant Biopharma Ltd. (10% Owner)	Buy	50,000	12.05	602,700
2020-04-27	Sumitovant Biopharma Ltd. (10% Owner)	Buy	40,503	12.18	493,286
2020-04-24	Sumitovant Biopharma Ltd. (10% Owner)	Buy	43,086	12.15	523,365
2020-04-23	Sumitovant Biopharma Ltd. (10% Owner)	Buy	35,000	12.35	432,110
2020-04-22	Sumitovant Biopharma Ltd. (10% Owner)	Buy	50,000	11.94	596,750
2020-04-21	Sumitovant Biopharma Ltd. (10% Owner)	Buy	50,200	11.58	581,165
2020-04-20	Sumitovant Biopharma Ltd. (10% Owner)	Buy	50,300	11.82	594,445
2020-04-17	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	10.77	753,550
2020-04-16	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	10.64	744,660
2020-04-15	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	10.48	733,670
2020-04-14	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	11.00	770,140
2020-04-13	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	9.81	686,560
2020-04-09	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	9.37	655,690
2020-04-08	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	8.53	596,960
2020-04-07	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	8.21	574,350
2020-04-06	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	8.44	590,520
2020-04-03	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	7.93	554,960
2020-04-02	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	7.73	541,100
2020-04-01	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	7.46	522,270
2020-03-31	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	7.97	557,970
2020-03-30	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	7.65	535,780
2020-03-27	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	7.97	558,250
2020-03-26	Sumitovant Biopharma Ltd. (10% Owner)	Buy	70,000	7.94	555,800
2020-03-25	Sumitovant Biopharma Ltd. (10% Owner)	Buy	108,100	7.60	821,884
2020-03-24	Sumitovant Biopharma Ltd. (10% Owner)	Buy	211,200	7.67	1,620,537
2020-03-23	Sumitovant Biopharma Ltd. (10% Owner)	Buy	211,200	7.68	1,622,016
2020-03-20	Sumitovant Biopharma Ltd. (10% Owner)	Buy	193,900	7.59	1,472,670
2020-03-19	Sumitovant Biopharma Ltd. (10% Owner)	Buy	193,900	7.68	1,488,958
2020-03-18	Sumitovant Biopharma Ltd. (10% Owner)	Buy	193,900	7.40	1,434,860
2020-03-18	Sablich Kim (Chief Commercial Officer)	Sale	785	7.16	5,616
2020-03-17	Sumitovant Biopharma Ltd. (10% Owner)	Buy	193,900	7.39	1,433,890
2020-03-16	Sumitovant Biopharma Ltd. (10% Owner)	Buy	193,900	7.25	1,405,968
2020-01-15	Sablich Kim (Chief Commercial Officer)	Sale	4,840	14.04	67,953
2019-12-30	Lang Matthew (General Counsel & Corp. Secy.)	Sale	19,018	15.55	295,729
2019-12-30	Karbe Frank (Principal Fin'l & Accounting)	Sale	19,701	15.55	306,350
2019-12-27	Roivant Sciences Ltd. (10% Owner)	Sale	45,008,604	.00	0
2019-12-18	Sablich Kim (Chief Commercial Officer)	Sale	2,585	16.22	41,928
2019-12-17	Roivant Sciences Ltd. (10% Owner)	Buy	75,000	15.94	1,195,500
2019-12-16	Roivant Sciences Ltd. (10% Owner)	Buy	170,000	15.32	2,605,250
2019-12-04	Roivant Sciences Ltd. (10% Owner)	Buy	75,000	17.30	1,297,500
2019-12-02	Roivant Sciences Ltd. (10% Owner)	Buy	179,193	18.53	3,320,446
2019-11-25	Roivant Sciences Ltd. (10% Owner)	Buy	3,500,000	15.00	52,500,000
2019-11-21	Roivant Sciences Ltd. (10% Owner)	Buy	121,906	12.09	1,473,843
2019-11-20	Roivant Sciences Ltd. (10% Owner)	Buy	121,906	12.90	1,572,587
2019-06-12	Sebelius Kathleen (Director)	Buy	5,000	8.94	44,700
2019-06-11	Karbe Frank (Principal Fin'l & Accounting)	Buy	8,000	9.10	72,800
2019-06-04	Svf Gp (jersey) Ltd (10% Owner)	Buy	2,424,242	8.25	19,999,996
2019-06-04	Shabet Rose Sharon	Buy	4,848,484	8.25	39,999,992
2019-06-04	Lo Andrew	Buy	2,424,242	8.25	19,999,996
2019-06-04	Oren Dan	Buy	2,424,242	8.25	19,999,996
2019-06-04	Roivant Sciences Ltd. (10% Owner)	Buy	2,424,242	8.25	19,999,996
2019-06-04	Qvt Fund V Lp (10% Owner)	Buy	2,424,242	8.25	19,999,996
2019-06-04	Machado Patrick (10% Owner)	Buy	2,424,242	8.25	19,999,996
2019-02-15	Arjona Ferreira Juan Camilo (Chief Medical Officer)	Sale	260	21.15	5,499
2018-04-02	Svf Gp (jersey) Ltd (10% Owner)	Buy	1,110,015	20.27	22,500,004
2018-04-02	Shabet Rose Sharon	Buy	1,110,015	20.27	22,500,004
2018-04-02	Lo Andrew (10% Owner)	Buy	1,110,015	20.27	22,500,004
2018-04-02	Oren Dan	Buy	1,110,015	20.27	22,500,004
2018-04-02	Roivant Sciences Ltd. (10% Owner)	Buy	1,110,015	20.27	22,500,004
2018-04-02	Viking Long Fund Gp Llc	Buy	1,110,015	20.27	22,500,004
2018-04-02	Qvt Fund V Lp (Director)	Buy	1,110,015	20.27	22,500,004
2018-04-02	Machado Patrick (10% Owner)	Buy	1,110,015	20.27	22,500,004
2018-03-19	Takeda Pharma A/s (10% Owner)	Buy	7,420,625	18.67	138,543,068
2018-03-19	Takeda Pharma A/s (10% Owner)	Sale	7,420,625	18.67	138,543,068
2017-11-17	Altmeyer Mark (Director)	Buy	3,500	13.38	46,830
2017-04-17	Takeda Pharmaceuticals International Ag (10% Owner)	Option Ex	4,432	.00	0
2017-03-15	Takeda Pharmaceuticals International Ag (10% Owner)	Option Ex	13,091	.00	0
2017-02-15	Takeda Pharmaceuticals International Ag (10% Owner)	Option Ex	6,845	.00	0
2017-01-17	Takeda Pharmaceuticals International Ag (10% Owner)	Option Ex	5,727	.00	0
2016-12-15	Takeda Pharmaceuticals International Ag (10% Owner)	Option Ex	22,141	.00	0
2016-11-01	Takeda Pharmaceuticals International Ag (10% Owner)	Option Ex	1,977,269	.00	0

Insider trading activities including stock purchases, stock sales, and option exercises of MYOV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Myovant Sciences Ltd. (symbol MYOV, CIK number 1679082) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month